基本信息
浏览量:28
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Basically a synthetic medicinal chemist, completed PhD in Pharmacy from Birla Institute of Technology in the Title "Design, Synthesis and Pharmacological Screening of Mycobactin Analogues"
Area of interest includes Molecular modeling and drug design and synthesis of small molecule heterocycles against targets of therapeutical importance. Molecular modeling includes Structure Based Drug Design (SBDD), Fragment Based Drug Design (FBDD), High-throughput Virtual Screening (HTVS) and Molecular Dynamics (MD). Targets under investigation are (i) Biosynthetic enzymes in the pathway of Mycobactin synthesis-target for anti-tubercular drug design; (ii) Histone deacetylase and Ribonucleotide-anti-cancer; (iii) protease, methyl-transferase & E-protein-anti-viral and (iv) MAO-neurodegenerative disorder. Chemical scaffolds designed: pyrazolines, aminothiazoles, thiosemicarbazones and piperazines.
研究兴趣
论文共 141 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European Journal of Medicinal Chemistry Reports (2024): 100148
Antonio Laghezza,Carmen Cerchia,Massimo Genovese,Roberta Montanari,Davide Capelli,Judith Wackerlig, Stefan Simic, Emanuele Falbo, Lucia Pecora,Rosalba Leuci,Leonardo Brunetti,Luca Piemontese,
European Journal of Medicinal Chemistrypp.116567, (2024)
Frontiers in Antibiotics (2024)
Antonio Laghezza,Carmen Cerchia,Massimo Genovese,Roberta Montanari,Davide Capelli,Judith Wackerlig, Stefan Simic, Emanuele Falbo, Lucia Pecora,Rosalba Leuci,Leonardo Brunetti,Luca Piemontese,
European journal of medicinal chemistry (2024): 116567-116567
Elsevier eBookspp.195-212, (2023)
Phytochemistry, Computational Tools and Databases in Drug Discoverypp.335-355, (2023)
Chemical biology & drug design (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn